ABL Diagnostics (XPAR:ABLD) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Change In Payables And Accrued Expense?

ABL Diagnostics's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was €0.00 Mil. It means ABL Diagnostics's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Jun. 2023 .

ABL Diagnostics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means ABL Diagnostics's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .

ABL Diagnostics Change In Payables And Accrued Expense Historical Data

The historical data trend for ABL Diagnostics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Change In Payables And Accrued Expense Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

ABL Diagnostics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

ABL Diagnostics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines